Until recently the scientific community accepted aging as something natural and inevitable, but now it is seen as a master disease that is treatable, can be slowed, even reversed.
This transformative perspective has ignited a new era of research and innovation, leading to remarkable breakthroughs in combating the effects of aging.
We now possess a much better understanding of the pathophysiology of age-related eye conditions, and it is evident that the root cause is genetic. Equipped with new gene therapy techniques, we have the potential to not only significantly slow down the progression of ocular diseases but also facilitate their reversal, including the regeneration of the optic nerve.
Glaucoma is the leading cause of irreversible blindness worldwide.
We are currently developing a groundbreaking approach that utilizes gene therapy to regenerate the damaged optic nerve while at the same time providing neuroprotection.
This discovery represents a potential cure for glaucoma that has the ability to restore patients' lost vision, something previously considered impossible.
The delivery of our gene therapy to the optic nerve is accomplished through a minimally invasive outpatient procedure known as intravitreal injection. This approach eliminates the need for invasive surgery, making it a convenient and accessible option for patients.
Targeting the crystalline lens with gene therapy to avoid alterations in its structure, morphology and function that leads initially to the diminished ability to focus in different distances (presbyopia) and later to opacification that severely impairs visual acuity and the perception of images and colors (cataract).
© 2023 GENORASIS™ - All rights reserved